CNSystems
奧地利CNSystems www.cnsystems.at
CNSystems, founded in 1998 to commercialize a research project started by the Technical and Medical University in Graz, is a venture backed company with headquarters in Graz, Austria and a subsidiary in Germany. The company is technology leader in non-invasive and continuous blood pressure monitoring.
The company succeeds in selling its devices either through its own sales force or through marketing and sales partnerships. Furthermore, the company co-operates with strong global players, renowned enterprises leading in medical equipment.
Among CNSystems' renowned key-users range not only clinics such as the Charité-Hospital in Berlin, the Mayo Clinic in Phoenix/Arizona or the General Hospital in Vienna, but also Research Institutes such as the NASA where the company supports projects in the field of space medicine.
In January 2003 CNSystems received the Austrian National Award of Innovation and was furthermore the only Austrian enterprise to be among the Red Herring Top 100 Europe in 2005.
CNSystems Medizintechnik AG is an Austrian company specialized in the development of non-invasive medical devices designed for the real-time evaluation of all medical conditions which are characterized by rapid and short-term changes in haemodynamics and autonomic CV-control parameters as well.
The broad range of applications by using the CNSystems' solutions offers a surplus value in many different medical fields closing the cycle of prevention, (early) diagnosis and monitoring.
The company succeeded in revolutionise the cardiovascular assessment by its main product, the Task Force® Monitor (Syncope assessment, AV-optimisation of CRT-pacemakers, e.g.) and establish the method of continuous non-invasive BP-monitoring also in perioperative, post anaesthesia and intensive care e.g. with a new product, the CNAP™ Monitor 500.
The focus consists in raising the level of information to physicians and decreasing pain and risk of complications for the patients making as a result first class medical treatment cheaper and therefore affordable to the patients.
